Delivery Order SPE2DB20D3101-SPE2DB22FK2C0
- Not listed
- This federal contract award is for the delivery of Novolog 100 unit/mL Flexpen 3mL to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,084.80 and is a firm fixed-price delivery order that runs through March 23, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL to the Defense Logistics Agency (DLA). The $1,329.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 25, 2022, with a completion date of March 28, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,225.44 Firm Fixed Price delivery order contract is for the supply of NovologTM 100 unit/mL FlexPenTM 3mL, a medication used for diabetes management. The contract has an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, an insulin medication, to the Defense Logistics Agency (DLA). The contract, valued at $3,537.60, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NovologĀ® 100 unit/mL FlexPen 3mL. The $2,445.30 firm-fixed-price contract has a completion date of December 6, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award is for the delivery of Novolog® 100 unit/mL FlexPen® 3mL to the Defense Logistics Agency (DLA). The $1,426.09 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 23, 2025, with a completion date of January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is for the delivery of Novolog 100 Unit/mL FlexPen 3mL, a type of insulin medication, to the Defense Logistics Agency (DLA). The $1,361.60 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 24, 2022, with a performance completion date of June 27, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,551.55, is for the delivery of Novolog 100 Unit/mL Flexpen 3mL, a type of insulin delivery device. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The $4,035.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is not designated as a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds significant...
- This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, and has a ceiling value of $1,318.08. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to $999,999,999.00 and runs...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK2C0Delivery Order
This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,838.16 and was awarded on June 23, 2022, with a completion date of June 24, 2022. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Cencora, Inc. also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/23/22 |